When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ARVN - Arvinas launches clinical development of ARV-471
Arvinas Inc.
Arvinas (NASDAQ:ARVN) initiates its second clinical program with the launch of a Phase 1 study assessing ARV-471 in patients with locally advanced/metastatic ER+/HER2- breast cancer. Preliminary data should be available in 2020.
More news on: Arvinas, Inc., Healthcare stocks news,